• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Journal PharmaceuticalIntelligence.com
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2022 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • SOP Web STAT
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

Rosalind Codrington, PhD — Inventor of Biologics and Diagnostics

INACTIVE, 2/21/2016 – Rosalind Codrington, PhD — Inventor of Biologics and Diagnostics

Roles at GDE: LPBI & M3DP

EAW Status Changed to Inactive on 2/19/2016

  • Inventor of Biologics and Diagnostics
  • Expert, Author, Writer
  1. CANCER BIOLOGY & Innovations in Cancer Therapy
  2. Nanotechnology for Drug Delivery
  3. Cell Biology, Signaling & Cell Circuits
  • Developer of Intellectual Property on Medical 3D BioPrinting: R&D Biologics, Genomics and Tissue Engineering

Rosalind Codrington, PhD

 07795140423

r.codrington@abeterno.com

BIO

10+ years experience as a molecular biologist in the field of antibody fragments, cell-based assays, protein production and purification and more recently in nanoparticles. I have mostly worked with screening methods to discover new antibody fragments against known oncogenes including fusion proteins resulting from chromosomal translocations. I have also worked with animal models with the aim to study the biology of leukaemias and ultimately test the efficacy of antibody fragments as potential therapeutic molecules. Following my postdoctoral fellowships I moved into the private sector where I worked as a senior scientist to validate novel tumour markers on prostate cancer stem cells. I then co-founded ABeterno Ltd, to develop a ground breaking new technology to be able to extract, purify and trace live cells with nanoparticles using intracellular proteins. I am currently involved as well in an exciting new website project designed to promote freelance scientists, the Cambridge science network http://cambridgesciencenetwork.com

CAREER HISTORY

 

Cambridge Science Network Ltd, Cambridge. July 2015-current

Co-founder

http://cambridgesciencenetwork.com

A website designed to put in touch freelance scientists with companies and laboratory spaces to rent. This is a place, which will enable freelance scientists and companies showcase their skills and services and put them in touch with business leaders, thereby promoting their businesses.

 

ABeterno Ltd, Cambridge. Sept 2011–current

Scientific founder and CSO

I developed a novel cell isolation technology that makes use of magnetic nanoparticles to purify live cells using intracellular proteins. I set-up ABeterno Ltd to further develop the proof of concept. The project is an interface between molecular biology, cell biology, and chemistry. I have been involved in all of the operations including business development, project planning and hiring since the company set up.

Pro-cure Therapeutics Ltd, York. Nov 2010-July 2011

Senior Research Scientist

I had direct reporting responsibility to the senior management team, and I managed several projects in target validation for prostate cancer. I maintained several prostate cancer cell lines and performed knockout studies with siRNA and other cell based assays to validate the targets. Extracted and maintained primary prostate cancer initiating stem cells from patient biopsies.

 

University of Surrey, Guildford. Feb 2010–July 2010

Postdoctoral scientist

In this role I studied the role of oxidative stress in artherosclerotic lessions. During this time I was responsible for a PhD student and for developing a protocol to culture primary cells from carotid artery samples from mice.

 

University of Leeds, Department of Experimental Therapeutics Jan 2007– Jan 2010

Postdoctoral Research Fellow

I managed several projects mainly in the analysis and elucidation of the molecular pathways by which certain genes initiate leukaemias in vivo. I also worked on the generation of therapeutic antibody fragments against leukaemic targets using yeast two hybrid selection methods.

 

University of Cambridge, Department of Chemistry Jun 2005–Dec 2006

Postdoctoral Research Fellow

This project was an interface between molecular biology and biophysics. I worked on the telomerase complex to elucidate the stoichiometry of the complex at the single molecule level using single molecule fluorescence coincidence microscopy.

Royal Free Hospital, UCL, London, Sept 1998–Dec 2000

Research Assistant

I analysed patient biopsies with leukaemias to study the correlation between the incidence of alternative spliced forms with minimal residual disease.

EDUCATION

  • PhD at MRC-LMB, University of Cambridge; Molecular Biology Jan 2001–Dec 2004
  • Msc in Biomedical Sciences, University of Kingston, 1997-1998
  • Bsc in Biochemistry, Queen Mary College, University of London, 1993–1997

INTERESTS

iking, swimming and playing the accordion. I am fluent in spoken and written Spanish and have basic knowledge in French and German.

 

PATENTS

WO2013/038158: Rosalind Codrington, ABeterno Ltd. Intracellular Cell Selection

WO2014/167282: Rosalind Codrington, ABeterno Ltd, In vivo cell imaging

PUBLICATIONS

  1. McCormack MP, Young LF, Vasudevan S, de Graaf CA, Codrington R, Rabbitts TH, Jane SM, Curtis DJ. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science. 2010 Feb 12;327(5967):879-83
  2. David Alves , Haitao Li , Rosalind Codrington , Angel Orte , Xiaojun Ren , David Klenerman, Shankar Balasubramanian. Single-molecule analysis of human telomerase monomer. Nat Chem Biol. 2008 May;4(5):287-9
  1. Forster A, Pannell R, Drynan L, Cano F, Chan N, Codrington   R, Daser A, Lobato N, Metzler M, Nam CH, Rodriguez S, Tanaka T, Rabbitts T. Chromosomal translocation engineering to recapitulate primary events of human cancer. Cold Spring Harbor Symposia on Quantitative Biology 2005 Sep,70:275-282
  1. Codrington R, Pannell R, Foster A, Drynan LF, Daser A, Lobato N, Metzler M, Rabbitts TH. A novel Cre-loxP-mediated chromosomal translocation model demonstrates the versatility of the Ewing’s sarcoma fusion protein. PLoS Biol. 2005 Aug;3(8):e242
  1. Foster A, Pannell R, Drynan L, Codrington R, Daser A, Metzler M, lobato N, Rabbitts TH. The invertor knock-in conditional chromosomal translocation mimic. Nature Methods 2005 Jan; 2(1) 
  1. Codrington R, O’Connor HE, Jalali GR, Carrara P, Papaioannou M, Hart SM, Hoffbrand AV, Potter M, Prentice HG, Harrison CJ, Foroni L. Analysis of ETV6/AML1 abnormalities in ALL: Incidence, alternative spliced forms and minimal residual disease Value. Br J Haematology

Dual Nationality: British and Swiss

Languages: French, Spanish, German

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to print (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 1,999 other subscribers
  • Recent Posts

    • Near Term Investment Outlook for 2023: A Perspective from Advisors Potentially Affecting M&A Landscape August 5, 2022
    • SOP for production of WordClouds for articles in the NEW GENRE Audio English-Spanish: BioMed e-Series – 18 Volumes in Medicine July 25, 2022
    • Cardiothoracic surgeons at UC San Francisco performed the first robotically assisted mitral valve prolapse surgery in San Francisco. July 22, 2022
    • Explanation on “Results of Medical Text Analysis with Natural Language Processing (NLP) presented in LPBI Group’s NEW GENRE Edition: NLP” on Genomics content, standalone volume in Series B and NLP on Cancer content as Part B New Genre Volume 1 in Series C   July 7, 2022
    • Sperm damage and fertility problem due to COVID-19 June 23, 2022
    • Genomic data can predict miscarriage and IVF failure June 15, 2022
    • The Human Genome Gets Fully Sequenced: A Simplistic Take on Century Long Effort June 14, 2022
    • Aortic Valve Transplant Via Carotid Artery at Hadassah – An Israel First May 29, 2022
    • Omecamtiv mecarbil – A study examined efficacy and tolerability in Heart Failure patients with SBP ≤100 mmHg enrolled in GALACTIC-HF May 23, 2022
    • Sperm epigenetic clock and pregnancy outcomes May 14, 2022
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 Amandeep Kaur
    • 1 Aashir Awan, Phd
    • 1 Abhisar Anand
    • 1 Adina Hazan
    • 1 Alan F. Kaul, PharmD., MS, MBA, FCCP
    • 1 alexcrystal6
    • 1 anamikasarkar
    • 1 apreconasia
    • 1 aviralvatsa
    • 1 David Orchard-Webb, PhD
    • 1 danutdaagmailcom
    • 1 Demet Sag, Ph.D., CRA, GCP
    • 1 Dror Nir
    • 1 dsmolyar
    • 1 Ethan Coomber
    • 1 evelinacohn
    • 1 Gail S Thornton
    • 1 Irina Robu
    • 1 jayzmit48
    • 1 jdpmd
    • 1 jshertok
    • 1 kellyperlman
    • 1 Ed Kislauskis
    • 1 larryhbern
    • 1 Madison Davis
    • 1 marzankhan
    • 1 megbaker58
    • 1 ofermar2020
    • 1 Dr. Pati
    • 1 pkandala
    • 1 Rosalind Codrington, PhD
    • 1 ritusaxena
    • 1 Rick Mandahl
    • 1 sjwilliamspa
    • 1 Srinivas Sriram
    • 1 stuartlpbi
    • 1 Dr. Sudipta Saha
    • 1 tildabarliya
    • 1 vaishnavee24
    • 1 zraviv06
    • 1 zs22

Powered by WordPress.com.

WPThemes.


%d bloggers like this: